Increased Surgical Site Infection Rates following Clindamycin Use in Head and Neck Free Tissue Transfer

Christopher Pool1, Jason Kass2, John Spivack3

  • 1Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Abstract

Insights

Clindamycin use in head and neck free tissue transfers increased surgical site infections (SSIs) risk by fourfold in penicillin-allergic patients. Alternative antibiotics with broader coverage are recommended to prevent SSIs.

Area of Science:

  • Surgical Oncology
  • Infectious Disease
  • Oral and Maxillofacial Surgery

Background:

  • Surgical site infections (SSIs) compromise free tissue transfer viability, leading to increased morbidity and hospitalization.
  • Current guidelines recommend clindamycin for penicillin-allergic patients undergoing head and neck reconstruction.

Purpose of the Study:

  • To evaluate postoperative infection rates associated with prophylactic antibiotic regimens, specifically clindamycin, in head and neck free tissue transfers.
  • To identify the risk of SSIs in patients receiving clindamycin due to penicillin allergy.

Main Methods:

  • Retrospective case series with chart review of 266 patients undergoing free tissue transfer for head and neck cancer reconstruction (2009-2014).
  • Analysis of demographic data, comorbidities, tumor characteristics, surgical procedures, and prophylactic antibiotic regimens.
  • Multivariate logistic regression to determine SSI risk factors; review of culture data.

Main Results:

  • Clindamycin use was associated with a nearly 4-fold increased risk of SSIs (OR, 3.784; P = .010) after adjusting for confounding factors.
  • The study controlled for potential variables influencing SSI development.

Conclusions:

  • Clindamycin may be linked to a higher incidence of SSIs in head and neck free tissue transfers for penicillin-allergic patients.
  • Broader gram-negative coverage with alternative antibiotics, such as cefuroxime, is recommended for penicillin-allergic patients undergoing these procedures.